We are live on
!
Find out more
RM
RP Management Portfolio holdings
AUM
$139M
1-Year Est. Return
37.98%
This Fund
S&P 500
This Quarter
Est. Return
-15.65%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$146M
AUM Growth
–
Cap. Flow
+$169M
Cap. Flow
% of AUM
116.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$86.8M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$76.1M |
| 3 |
Cytokinetics
CYTK
|
+$6.42M |
| 4 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
+$151K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 57.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $78.1M | 53.45% |
+2,111,111
| New | +$76.1M |
|
|
IMMU
2
DELISTED
Immunomedics Inc
IMMU
| $62.4M | 42.73% |
+4,373,178
| New | +$86.8M |
|
|
3
Cytokinetics
CYTK
$11.5B
| $5.53M | 3.79% |
+875,656
| New | +$6.42M |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $54K | 0.04% |
+3,700
| New | +$151K |
|
Similar funds
PC
LA
TP
SC
MFG
MADFP
RM
NC